We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The Africa Centres for Disease Prevention and Control report continued transmission of dengue in African countries.
From 1 January 2024 to 9 February 2024, the following countries have reported dengue cases:
Ethiopia: 1 561 cases
Mali: 925 cases
Mauritius: 600 cases (2 deaths)
Sao Tome & Principe: 9 cases
Dengue virus is spread by Aedes mosquito bites and can cause a flu-like illness, sometimes leading to severe or life-threatening disease.
Dengue is an infection found in tropical and sub-tropical climates worldwide.
All travellers to endemic regions are potentially at risk of dengue fever and should be aware of this infection.
Aedes mosquitoes are particularly persistent and aggressive. They bite between dawn and dusk.
A new dengue vaccine Qdenga® has been licensed in the UK and is awaiting JCVI recommendations for use.
Travellers developing a fever during or on return from travel are advised to seek medical attention as soon as possible.
For further information see TRAVAX dengue fever page.
